Page last updated: 2024-08-23

cabergoline and Weight Gain

cabergoline has been researched along with Weight Gain in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Auriemma, RS; Colao, A; Graziadio, C; Pirchio, R; Pivonello, R1
Grattan, D; Manning, PJ; Manning, T; Merriman, T; Sutherland, W; Williams, S1
Barbosa, FR; Domingues, RC; dos Santos Silva, CM; Fontes, R; Gadelha, MR; Lima, GA; Warszawski, L1
Biondi, B; Briganti, F; Cappabianca, P; Colao, A; Faggiano, A; Lombardi, G; Pivonello, R; Sarno, AD; Somma, CD1

Reviews

1 review(s) available for cabergoline and Weight Gain

ArticleYear
Metabolic effects of prolactin.
    Frontiers in endocrinology, 2022, Volume: 13

    Topics: Bromocriptine; Cabergoline; Dopamine; Dopamine Agonists; Glucose; Humans; Hyperprolactinemia; Lipids; Male; Metabolic Syndrome; Obesity; Prolactin; Receptors, Dopamine; Receptors, Prolactin; Testosterone; Weight Gain

2022

Trials

2 trial(s) available for cabergoline and Weight Gain

ArticleYear
Pharmaceutical interventions for weight-loss maintenance: no effect from cabergoline.
    International journal of obesity (2005), 2018, Volume: 42, Issue:11

    Topics: Adult; Cabergoline; Diet, Reducing; Dopamine Agonists; Double-Blind Method; Female; Humans; Male; Middle Aged; Obesity; Secondary Prevention; Treatment Outcome; Weight Gain; Weight Loss; Young Adult

2018
Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia.
    European journal of endocrinology, 2003, Volume: 148, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cabergoline; Ergolines; Female; Follow-Up Studies; Galactose; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Prospective Studies; Sex Characteristics; Sexual Dysfunction, Physiological; Treatment Outcome; Visual Fields; Weight Gain

2003

Other Studies

1 other study(ies) available for cabergoline and Weight Gain

ArticleYear
BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists.
    Obesity (Silver Spring, Md.), 2011, Volume: 19, Issue:4

    Topics: Adult; Aftercare; Aged; Blood Glucose; Body Composition; Body Mass Index; Body Weight; Bromocriptine; Cabergoline; Cholesterol, HDL; Cholesterol, LDL; Dopamine Agonists; Ergolines; Female; Humans; Insulin; Insulin Resistance; Leptin; Male; Metabolic Syndrome; Metabolome; Middle Aged; Obesity; Prevalence; Prolactinoma; Waist Circumference; Weight Gain; Young Adult

2011